Skip to main content

Table 2 Baseline test score table

From: Repetitive transcranial magnetic stimulation improves cognition, depression, and walking ability in patients with Parkinson’s disease: a meta-analysis

 

Outcome measures

Study (Patient)

SMD(95%CI)

P-value of the intervention effect

Heterogeneity

Cognitive function

MOCA

3(n = 175)

0.103,(-0.195;0.401)

P = 0.496

I2 = 0%, P = 0.544

Depressive symptoms

HAMD

4(n = 168)

0.071,(-0.219;0.362)

P = 0.631

I2 = 2.6%, P = 0.392

Walk ability

FOG-Q

3(n = 90)

0.023,(-0.398;0.444)

P = 0.915

I2 = 0%, P = 0.967

 

TUGT

5(n = 178)

-0.182,(-0.470; 0.106)

P = 0.216

I2 = 4%, P = 0.108;

 

UPDRSIII

11(n = 489)

-0.03,(-0.203;0.142)

P = 0.730

I2 = 0%, P = 0.993

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us